BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18542839)

  • 1. Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial.
    Düngen HD; Apostolović S; Inkrot S; Tahirović E; Krackhardt F; Pavlović M; Putniković B; Lainscak M; Gelbrich G; Edelmann F; Wachter R; Eschenhagen T; Waagstein F; Follath F; Rauchhaus M; Haverkamp W; Osterziel KJ; Dietz R;
    Clin Res Cardiol; 2008 Sep; 97(9):578-86. PubMed ID: 18542839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial.
    Düngen HD; Apostolovic S; Inkrot S; Tahirovic E; Töpper A; Mehrhof F; Prettin C; Putnikovic B; Neskovic AN; Krotin M; Sakac D; Lainscak M; Edelmann F; Wachter R; Rau T; Eschenhagen T; Doehner W; Anker SD; Waagstein F; Herrmann-Lingen C; Gelbrich G; Dietz R;
    Eur J Heart Fail; 2011 Jun; 13(6):670-80. PubMed ID: 21429992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-blockers in heart failure. The 'new wave' of clinical trials.
    Krum H
    Drugs; 1999 Aug; 58(2):203-10. PubMed ID: 10473016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of change in quality of life in the Cardiac Insufficiency Bisoprolol Study in Elderly (CIBIS-ELD).
    Scherer M; Düngen HD; Inkrot S; Tahirović E; Lashki DJ; Apostolović S; Edelmann F; Wachter R; Loncar G; Haverkamp W; Neskovic A; Herrmann-Lingen C
    Eur J Intern Med; 2013 Jun; 24(4):333-8. PubMed ID: 23375618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease.
    Kubota Y; Asai K; Furuse E; Nakamura S; Murai K; Tsukada YT; Shimizu W
    Int J Chron Obstruct Pulmon Dis; 2015; 10():515-23. PubMed ID: 25784798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of bisoprolol fumarate compared with carvedilol in Japanese patients with chronic heart failure: results of the randomized, controlled, double-blind, Multistep Administration of bisoprolol IN Chronic Heart Failure II (MAIN-CHF II) study.
    Hori M; Nagai R; Izumi T; Matsuzaki M
    Heart Vessels; 2014 Mar; 29(2):238-47. PubMed ID: 23559359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Congestive heart failure in Spain: cost-effectiveness and cost-benefit analyses of treatment with beta-blockers].
    Díez Manglano J
    Rev Clin Esp; 2005 Apr; 205(4):149-56. PubMed ID: 15860185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for beta-blocker selection.
    Chin BS; Gibbs CR; Blann AD; Lip GY
    Clin Sci (Lond); 2003 Oct; 105(4):507-12. PubMed ID: 12841846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure.
    Fröhlich H; Torres L; Täger T; Schellberg D; Corletto A; Kazmi S; Goode K; Grundtvig M; Hole T; Katus HA; Cleland JGF; Atar D; Clark AL; Agewall S; Frankenstein L
    Clin Res Cardiol; 2017 Sep; 106(9):711-721. PubMed ID: 28434020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung function with carvedilol and bisoprolol in chronic heart failure: is beta selectivity relevant?
    Agostoni P; Contini M; Cattadori G; Apostolo A; Sciomer S; Bussotti M; Palermo P; Fiorentini C
    Eur J Heart Fail; 2007 Aug; 9(8):827-33. PubMed ID: 17561440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of selective and non-selective beta-blockers on body weight, insulin resistance and leptin concentration in chronic heart failure.
    Kovacić D; Marinsek M; Gobec L; Lainscak M; Podbregar M
    Clin Res Cardiol; 2008 Jan; 97(1):24-31. PubMed ID: 17694376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evaluation of β-adrenoceptor blocking agents in patients with COPD and congestive heart failure: a nationwide study.
    Liao KM; Lin TY; Huang YB; Kuo CC; Chen CY
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2573-2581. PubMed ID: 28894360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New milestones in the therapy of chronic heart failure with beta blockers].
    Garlichs C; Daniel WG
    Z Kardiol; 2000 Mar; 89(3):236-8. PubMed ID: 10798280
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative effects of carvedilol vs bisoprolol for severe congestive heart failure.
    Konishi M; Haraguchi G; Kimura S; Inagaki H; Kawabata M; Hachiya H; Hirao K; Isobe M
    Circ J; 2010 Jun; 74(6):1127-34. PubMed ID: 20354334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Older adults with heart failure treated with carvedilol, bisoprolol, or metoprolol tartrate: risk of mortality.
    Perreault S; de Denus S; White M; White-Guay B; Bouvier M; Dorais M; Dubé MP; Rouleau JL; Tardif JC; Jenna S; Haibe-Kains B; Leduc R; Deblois D
    Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):81-90. PubMed ID: 27859924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisoprolol in the treatment of chronic heart failure.
    de Groote P; Ennezat PV; Mouquet F
    Vasc Health Risk Manag; 2007; 3(4):431-9. PubMed ID: 17969374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.
    Tang CH; Wang CC; Chen TH; Hong CY; Sue YM
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26738790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In heart failure, all beta-blockers are not necessarily equal.
    Tang WH; Militello M; Francis GS
    Cleve Clin J Med; 2003 Dec; 70(12):1081-7. PubMed ID: 14686687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carvedilol, Bisoprolol, and Metoprolol Use in Patients With Coexistent Heart Failure and Chronic Obstructive Pulmonary Disease.
    Su VY; Chang YS; Hu YW; Hung MH; Ou SM; Lee FY; Chou KT; Yang KY; Perng DW; Chen TJ; Liu CJ
    Medicine (Baltimore); 2016 Feb; 95(5):e2427. PubMed ID: 26844454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.